Learn why FDA 'breakthrough' therapy designation often reflects expedited review, not proven clinical benefit, how to interpret evidence and avoid hype.
3 articles found in 1.62s
Learn why FDA 'breakthrough' therapy designation often reflects expedited review, not proven clinical benefit, how to interpret evidence and avoid hype.
Learn why clinical trial success rates often fail in daily practice. Understand the efficacy-effectiveness gap and interpret trial data accurately for your patients.
Master Step 3 ethics and risk management patterns: learn fast decision frameworks, capacity rules, surrogates, and high-yield strategies to save time and points.